The Latest
-
Cyclopharm share price rockets 22% higher on FDA application approval
-
Why Afterpay, CSL, Fortescue, & Newcrest shares are dropping lower
-
Why ALS, Metcash, NAB, & Pointsbet shares are racing higher
-
Hedge Funds Have Never Been This Bullish On DexCom, Inc. (DXCM)